在帕金森病的罗农诱导细胞模型中,哈尔帕戈西德对线粒体功能的保护作用
Juan Lang1, Zhongkui Xiong2,3
1Department of Pathology, Shaoxing People's Hospital, Shaoxing, Zhejiang 312000, P.R. China.
Biomedical reports
|February 24, 2025
概括
哈尔帕戈西德通过改善线粒体功能和帕金森症患者的细胞存活率来证明神经保护作用.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 是一种流行的神经退行性疾病,没有治愈方法.
- 来自特定植物来源的harpagoside正在研究其神经保护潜力.
研究的目的:
- 为了检查harpagoside对线粒体功能障碍在罗农诱导的帕金森病细胞模型中的影响.
- 为了评估哈帕戈西德对细胞活力,线粒体复合体I活性,胀和亡的影响.
主要方法:
- 已确定的帕金森病 (PD) 在体外模型中使用Neuro-2A (N2A) 细胞治疗罗.
- 通过细胞计数工具-8测定来评估细胞活力.
- 通过光谱光度测量测量了线粒体复合物I活性,胀和卡斯巴酶3活性.
主要成果:
- 轮治疗减少了细胞存活率,并诱导了线粒体功能障碍.
- 哈尔帕戈治疗显著增加了暴露于罗农的N2A细胞中的细胞存活率.
- 哈尔帕戈西德减轻了线粒体胀,增强了I复合体活性,并抑制了caspase3激活.
结论:
- 哈尔帕戈西德对罗诺诱导的线粒体损伤具有显著的神经保护性.
- 哈尔帕戈西德通过保护线粒体功能来证明其作为帕金森病治疗剂的潜力.
相关概念视频
Parkinson's Disease: Treatment
185
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
185
Electron Transport Chain: Complex I and II
10.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.2K
Parkinson's Disease: Overview
424
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
424


